Interleukin-10 Promotes Treg Formation and Tumorigenesis via Regulating Nrp-1/PDX1/FoxP3 Axis: Insights from...

Area of Science:

• Immunology and Cancer Biology
• Molecular Mechanisms of Tumorigenesis
• Immune Microenvironment Regulation

Background:

• Environmental factors like Interleukin-10 (IL-10) significantly influence tumor progression.
• The precise regulatory pathways by which IL-10 affects the tumor immune microenvironment remain incompletely understood.
• Regulatory T cells (Treg) play a crucial role in immune suppression within tumors.

Purpose of the Study:

• To elucidate the regulatory mechanism of IL-10 on Treg cells using in vitro assays.
• To investigate the role of the Nrp-1/PDX1 interaction in IL-10-mediated tumorigenesis in vivo.
• To identify potential therapeutic targets within the IL-10-Treg regulatory axis.

Main Methods:

• Isolation and induction of Treg cells from mouse spleen, treated with IL-10 and melanoma cell supernatant.
• Analysis of Nrp-1 and FoxP3 expression using qRT-PCR and Western blotting; Treg ratio assessed by flow cytometry.
• In vivo studies using melanoma xenograft and Nrp-1/PDX1 knockout mouse models to evaluate tumorigenesis.

Main Results:

• IL-10 was found to promote Nrp-1 expression in Treg cells via the JAK-STAT3 signaling pathway.
• Nrp-1 forms a complex with PDX1, enhancing PDX1-mediated activation of FoxP3 and subsequent Treg production.
• Targeting Nrp-1 and PDX1 significantly reduced Treg levels and inhibited tumor growth in melanoma models.

Conclusions:

• IL-10 promotes Treg formation and tumorigenesis through the novel Nrp-1/PDX1/FoxP3 regulatory axis.
• The interaction between Nrp-1 and PDX1 leads to PDX1 ubiquitination, enhancing FoxP3 expression and Treg function.
• The Nrp-1/PDX1/FoxP3 axis represents a critical regulator of Treg-mediated tumorigenesis and a potential target for cancer therapy.